Key clinical point: The histamine-2 receptor antagonist famotidine might improve symptoms of COVID-19 infections.
Major finding: Apart from two cases of anosmia, complete symptom resolution was reported within 14 days of initiating famotidine therapy.
Study details: Retrospective case series of 10 nonhospitalized patients.
Disclosures: The National Institutes of Health provided partial support. The investigators reported having no conflicts of interest.
Janowitz T et al. Gut. 2020 Jun 4. doi: 10.1136/gutjnl-2020-321852.